Karyopharm Therapeutics
Karim Kovacevic is a seasoned professional with extensive experience in commercial systems and sales operations within the pharmaceutical industry. Currently serving as the Director of Commercial Systems at Karyopharm Therapeutics Inc. since February 2021, Karim has previously held significant roles at Sunovion Pharmaceuticals, including Senior Manager and Manager in Field Enablement and System Architecture. Prior to that, Karim worked as a Solutions Architect at Mavens Consulting and as a Freelance Salesforce.com Consultant. Additional experience includes leadership positions at Astadia and Theikos, where Karim contributed as Director of Global Sales Operations and VP of Client Service, respectively. Karim began career development at Gomez, Inc. as a Product Marketing Manager. Educational qualifications include an MBA from the Rotterdam School of Management, an undergraduate degree in Economics from Western University, and a secondary degree from St. George's High School of Montreal.
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).